All Blogs

Dec 01, 2018

Let's go an extra mile to spread the word against #HIVAIDS This 30th World AIDS Day, let’s strengthen our efforts to prevent spread of #HIV & #AIDS. Mark your calendars, get yourself tested and know your status! #Prevention is better than #cure, especially when something has No Cure.  Have a glance at an infogra...

Nov 30, 2018

It is needless to mention that the tug-of-war between cancer and researchers has been growing stronger and stronger. On one side, cancer has positioned itself as a leading cause of death and on the other side, scientists have been working diligently to find out more effective cancer treatments. According to the Amer...

Nov 29, 2018

Prometic bags USD 50 Million stock sale option to ease a cash crunch Prometic Life Sciences got into an agreement for selling USD 50 million in stock. This gives Prometic a way to escape its current financial pressures. Canada-based Prometic was asked by the FDA to make and validate process changes for Ryplazim, a c...

Nov 28, 2018

The researchers announced that they had edited human embryos to repair a damaged gene that can lead to heart failure, but critics raised their eyebrows. Now, new evidence confirms that the gene editing was successful, said by reproductive and developmental biologist Shoukhrat Mitalipov of Oregon Health & Science...

Nov 26, 2018

Do you often sleep during work? Well, if you do so, you might proudly claim yourself to be an efficient and hard worker as work stress led you to doze off. Or, you might also advise others to do the same as the practice of sleeping at workplaces for short intervals, also called as power naps, is widely believed to r...

Nov 23, 2018

It is needless to mention that Chemotherapy has been the most dependable cancer therapy. But, a new area of research shows the possibility of technology taking over the role of dominant cancer therapy in the future and in the event of which chemotherapy will be pushed to redundancy, as speculated. There is an ongoin...

Nov 22, 2018

Cambrex takes over Avista in USD 250 Million agreement Cambrex, life sciences company, is taking over Avista Pharma Solutions with a deal of USD 250 million to become a leading contract development and manufacturing organization (CDMO). The agreement includes the early-stage drug development and manufacturing capabi...

Nov 21, 2018

Nov 21, 2018

The Mini brains grown in a dish have produced human-like brain waves. They are the electrical patterns look similar to those of premature babies. This would aid scientists to study early brain development. The research in this area has been sluggish, partly because it is difficult to obtain fetal-tissue samples for ...

Nov 20, 2018

Gene editing, a possible treatment, for inherited kidney disease Joubert syndrome, an inherited brain disorder that causes kidney failure in patients. This requires a transplant or dialysis. A mutation in the gene CEP290 causes the inherited form of kidney disease and scientists in the U.K. to apprise of having an e...